- 拓新藥業
- 28.850-0.200 (-0.688%)
盈利能力分析
- -1.962
- -1.260
- 16.316
- 23.166
- 8.275
- -1.750
- -1.106
- 13.202
- 17.704
- 5.616
- -1.910
- -1.222
- 15.150
- 20.536
- 6.490
邊際利潤分析
- 29.361
- 29.867
- 57.876
- 60.114
- 37.915
- -13.389
- -5.624
- 38.502
- 41.963
- 15.771
- -13.469
- -7.388
- 37.483
- 41.080
- 17.231
- -11.107
- -4.715
- 29.093
- 36.514
- 13.077
收益指標分析
- 103.584
- 82.829
- 100.573
- 97.553
- 99.308
- -9.072
- -5.600
- 2.248
- 1.775
- 0.806
- 0.415
- 14.475
- -1.627
- -1.236
- -1.542
償債能力分析
- 4.686
- 4.095
- 4.227
- 2.392
- 3.129
- 3.216
- 3.013
- 3.177
- 1.823
- 2.473
- 9.886
- 11.701
- 12.818
- 25.329
- 21.264
- 0.189
- 0.208
- 0.753
- 8.550
- 8.033
- 51,641.806
- 46,823.941
- 12,857.691
- 1,037.226
- 1,102.903
- 911.558
- 754.662
- 680.152
- 294.798
- 370.289
- 554.723
- 9.108
- -93.138
- -110.789
- 10.137
營運能力分析
- 77.958
- 98.289
- 41.735
- 22.814
- 33.946
- 260.168
- 233.101
- 227.715
- 234.763
- 188.665
大國博弈
貨幣攻略
More